Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6
Ying Zhao1,2, Jing Ruan3, Zhongding Li1
1Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Background:
CCN6 is a matricellular protein that critically regulates the tumourigenesis and progression of breast cancer. Although the tumour-suppressive function of CCN6 has been extensively studied, molecular mechanisms regulating protein levels of CCN6 remain largely unclear. This study aims to investigate the regulation of CCN6 by ubiquitination and deubiquitinating enzymes (DUBs) in breast cancer.
Methods:
A screening assay was performed to identify OTUB1 as the DUB for CCN6. Various biochemical methods were applied to elucidate the molecular mechanism of OTUB1 in the regulation of CCN6. The role of OTUB1-CCN6 interaction in breast cancer was studied with cell experiments and the allograft model. The correlation of OTUB1 and CCN6 in human breast cancer was determined by immunohistochemistry and Western blot.
Results:
We found that CCN6 protein levels were controlled by the ubiquitin-proteasome system. The K48 ubiquitination and degradation of CCN6 was inhibited by OTUB1, which directly interacted with CCN6 through its linker domain. Furthermore, OTUB1 inhibited the ubiquitination of CCN6 in a non-canonical manner. Deletion of OTUB1, concomitant with reduced CCN6 abundance, increased the migration, proliferation and viability of breast cancer cells. Supplementation of CCN6 abolished the effect of OTUB1 deletion on breast cancer. Importantly, OTUB1 expression was downregulated in human breast cancer and positively correlated with CCN6 levels.
Conclusion:
This study identified OTUB1 as a novel regulator of CCN6 in breast cancer.
Insights
OTUB1 deubiquitinates and stabilizes CCN6, a tumor suppressor in breast cancer. OTUB1 downregulation in breast cancer promotes tumor progression by reducing CCN6 levels.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- CCN6 is a critical matricellular protein regulating breast cancer tumorigenesis.
- Mechanisms controlling CCN6 protein levels, particularly via ubiquitination, are not well understood.
Purpose of the Study:
- To investigate the role of deubiquitinating enzymes (DUBs) in regulating CCN6 protein levels.
- To elucidate the specific DUB responsible for CCN6 regulation and its mechanism in breast cancer.
Main Methods:
- Screening assay to identify DUBs targeting CCN6.
- Biochemical assays to define the OTUB1-CCN6 interaction and mechanism.
- Cellular and in vivo models to assess the functional impact of OTUB1-CCN6 interaction.
- Immunohistochemistry and Western blot to analyze OTUB1 and CCN6 expression in human breast cancer tissues.
Main Results:
- OTUB1 was identified as a DUB that directly interacts with CCN6.
- OTUB1 inhibits K48-linked ubiquitination and proteasomal degradation of CCN6 in a non-canonical manner.
- OTUB1 downregulation in breast cancer leads to decreased CCN6 levels, enhancing cancer cell migration, proliferation, and viability.
- OTUB1 expression inversely correlates with breast cancer progression.
Conclusions:
- OTUB1 is a novel deubiquitinating enzyme that stabilizes the tumor suppressor CCN6 in breast cancer.
- OTUB1 acts as a potential therapeutic target for breast cancer treatment by restoring CCN6 levels.
Related Concept Videos
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Hedgehog Signaling Pathway

